Quest Reports 1 Percent Q4 Sales Dip | GenomeWeb

NEW YORK (GenomeWeb News) – Quest Diagnostics today reported that its fourth quarter sales were down around 1 percent year over year.

The clinical lab and diagnostic information services provider reported revenues of $1.76 billion for the three months ended Dec. 31, 2013, down one percent year over year from $1.77 billion. Analysts, on average, had estimated the firm's revenue for the quarter at around $1.74 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.